JP2024525760A5 - - Google Patents

Info

Publication number
JP2024525760A5
JP2024525760A5 JP2024501910A JP2024501910A JP2024525760A5 JP 2024525760 A5 JP2024525760 A5 JP 2024525760A5 JP 2024501910 A JP2024501910 A JP 2024501910A JP 2024501910 A JP2024501910 A JP 2024501910A JP 2024525760 A5 JP2024525760 A5 JP 2024525760A5
Authority
JP
Japan
Application number
JP2024501910A
Other languages
Japanese (ja)
Other versions
JP2024525760A (ja
JPWO2023288210A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/073626 external-priority patent/WO2023288210A1/en
Publication of JP2024525760A publication Critical patent/JP2024525760A/ja
Publication of JP2024525760A5 publication Critical patent/JP2024525760A5/ja
Publication of JPWO2023288210A5 publication Critical patent/JPWO2023288210A5/ja
Pending legal-status Critical Current

Links

JP2024501910A 2021-07-12 2022-07-12 小児患者のファブリー病を治療する方法 Pending JP2024525760A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163220816P 2021-07-12 2021-07-12
US63/220,816 2021-07-12
PCT/US2022/073626 WO2023288210A1 (en) 2021-07-12 2022-07-12 Methods of treating fabry disease in pediatric patients

Publications (3)

Publication Number Publication Date
JP2024525760A JP2024525760A (ja) 2024-07-12
JP2024525760A5 true JP2024525760A5 (https=) 2025-04-28
JPWO2023288210A5 JPWO2023288210A5 (https=) 2025-04-28

Family

ID=83149437

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024501910A Pending JP2024525760A (ja) 2021-07-12 2022-07-12 小児患者のファブリー病を治療する方法

Country Status (7)

Country Link
US (1) US20240293387A1 (https=)
EP (1) EP4370120A1 (https=)
JP (1) JP2024525760A (https=)
KR (1) KR20240034203A (https=)
AU (1) AU2022310691A1 (https=)
CA (1) CA3225511A1 (https=)
WO (1) WO2023288210A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3851105B1 (en) 2019-08-07 2026-03-04 Amicus Therapeutics, Inc. Migalastat for use in treating fabry disease in patients having a mutation in the gla gene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274597B1 (en) 1998-06-01 2001-08-14 Mount Sinai School Of Medicine Of New York University Method of enhancing lysosomal α-Galactosidase A
AU2008232614A1 (en) 2007-03-30 2008-10-09 Amicus Therapeutics, Inc. Method for the treatment of Fabry disease using pharmacological chaperones
SI3470077T1 (sl) 2008-02-12 2020-12-31 Amicus Therapeutics, Inc. Postopek za napovedovanje odgovora na zdravljenje bolezni s farmakološkim spremljevalcem

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
JP2024525760A5 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13143U (https=)
BY13167U (https=)
BY13137U (https=)
BY13140U (https=)
BY13141U (https=)
BY13170U (https=)
BY13142U (https=)
BY13158U (https=)